Needham Maintains Buy on Hinge Health, Raises Price Target to $115

Benzinga Newsdesk www.benzinga.com Positive 71.0%

Neg 0% Neu 0% Pos 71%

Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $97 to $115.